Actively Recruiting
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Led by King Edward Medical University · Updated on 2025-03-11
152
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months
CONDITIONS
Official Title
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of acute coronary syndrome
- 25 hydroxy Vitamin D levels between 30 and 70 ng/ml
- Age between 18 and 65 years
You will not qualify if you...
- Hypercalcemia
- Hypocalcemia
- Pregnancy
- Breastfeeding
- Hypersensitivity to statins
- Hypothyroidism
- Abnormal liver function tests (LFTs) or kidney function tests (RFTs)
- Use of Vitamin D supplements, lipid lowering drugs, anti-obesity drugs, or corticosteroids within the last 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
King Edward Medical University
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
A
Ali Hussnain
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here